Tailstorm Health recalls
FDA enforcement reports naming Tailstorm Health INC as the recalling firm.
- Recall reports
- 8
- Class I (serious)
- 0
- Most recent report
- Jul 9, 2025
- Jul 9, 2025LIDOcaine HCL Sterile Injection, USP, 20 mg/mL, 2%, (200 mg/10 mL), For Infiltration &…Drug · Tailstorm Health INCLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.Class II
- Jul 9, 2025KETAmine Hydrochloride Injection, USP, 500mg/5mL, (10mg/mL), For IM or Slow IV Use, 5mL…Drug · Tailstorm Health INCLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.Class II
- Jul 9, 2025LIDOcaine HCL Sterile Injection, USP, 100mg/10mL, 1%, (10mg/mL), w/EPINEPHRINE 1:100,00…Drug · Tailstorm Health INCLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.Class II
- Jul 9, 2025LIDOcaine HCl Injection, USP, 10mg/mL, 1% (100 mg/10mL), 10 mL Sterile Single Dose Vial…Drug · Tailstorm Health INCLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.Class II
- Jul 9, 2025BUPIVAcaine HCL Sterile injection, USP w/EPINEPHRINE 1:200,000, 50 mg/10mL, 0Drug · Tailstorm Health INCLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.Class II
- Jul 9, 2025KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use,…Drug · Tailstorm Health INCLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.Class II
- Nov 27, 2024BEVACIZUMAB (AVASTIN)1Drug · Tailstorm Health INCLack of Sterility AssuranceClass II
- Jul 17, 2024Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10…Drug · TAILSTORM HEALTH INCSubpotent Drug: reduced efficacy for epinephrineClass II